ArticleProceedings of the National Academy of Sciences of the United States of America2017

Therapeutically targeting glypican-2 via single-domain antibody-based chimeric antigen receptors and immunotoxins in neuroblastoma.

Nan Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.